Wuppertal, Germany

Ulrich Horlein


Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 31(Granted Patents)


Location History:

  • Wupperthal, DE (1980)
  • Wuppertal, DE (1976 - 1986)

Company Filing History:


Years Active: 1976-1986

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ulrich Horlein: Innovator in Antithrombotic Research

Introduction

Ulrich Horlein is a prominent inventor based in Wuppertal, Germany, known for his significant contributions to the field of medicinal chemistry. With a total of five patents to his name, Horlein has focused on developing innovative compounds that can serve as antithrombotic agents.

Latest Patents

Horlein's latest patents include groundbreaking work on thrombin inhibitory new dihydroxybenzene ether derivatives. These ether derivatives are characterized by complex formulas that enable a range of chemical substitutions. Additionally, he has developed anti-thrombotic 1,2-benzisothiazolin-3-ones. These compounds, particularly the 2-(2-diethylaminoethyl)-4,5-dimethyl-1,2-benzisothiazolin-3-one, exemplify the potential for innovative treatment options in thrombosis management.

Career Highlights

Ulrich Horlein is affiliated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has positioned him at the intersection of research and practical application, highlighting his role in advancing medical science through innovative drug development.

Collaborations

Throughout his career, Horlein has collaborated with esteemed colleagues, including Horst Boshagen and Friedel Seuter. These partnerships have fostered a collaborative environment conducive to innovation, leading to significant advancements in pharmacological research.

Conclusion

Ulrich Horlein's contributions to the field of medicinal chemistry and his innovative patents underscore the importance of new developments in antithrombotic agents. Through his work at Bayer Aktiengesellschaft and his collaborations with notable peers, Horlein continues to play a crucial role in the evolution of medical therapies. His patents represent a significant step forward in the quest to address complex health issues related to thrombosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…